Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.347 SEK | -0.57% | +7.43% | +35.55% |
Apr. 05 | Index Pharmaceuticals Holding AB Announces Board Resignations | CI |
Mar. 26 | InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 186M 2.02B |
---|---|---|---|---|---|
Net income 2024 * | -259M -2.82B | Net income 2025 * | -221M -2.4B | EV / Sales 2024 * | - |
Net Debt 2024 * | 86.32M 939M | Net Debt 2025 * | 306M 3.33B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.71
x | P/E ratio 2025 * |
-0.85
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.47% |
1 day | -0.57% | ||
1 week | +7.43% | ||
Current month | +18.84% | ||
1 month | +16.84% | ||
3 months | +52.19% | ||
6 months | -56.84% | ||
Current year | +35.55% |
Managers | Title | Age | Since |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 22-12-31 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 17-04-30 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 15-12-31 |
Director/Board Member | 68 | 10-12-31 | |
Chairman | 72 | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.347 | -0.57% | 595 677 |
24-04-22 | 0.349 | +6.08% | 5,708,429 |
24-04-19 | 0.329 | 0.00% | 1,089,139 |
24-04-18 | 0.329 | +0.92% | 1,955,664 |
24-04-17 | 0.326 | +0.93% | 2,642,382 |
Delayed Quote Nasdaq Stockholm, April 23, 2024 at 05:38 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+35.55% | 17.03M | |
+25.46% | 659B | |
+26.67% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.26% | 215B | |
+8.08% | 210B | |
-6.01% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- INDEX Stock